Michael Dowell Analyzes How Telepharmacy is Combating Pharmacy Closures and Improving Health Equity

Published as a Byline in the October 2025 Edition of the U.S. Pharmacist

Share this page
Print
PDF

In The News | 1 min read

Oct 10, 2025

Hinshaw partner Michael Dowell authored a byline published in the October 2025 edition of the U.S. Pharmacist, which explores how telepharmacy and remote dispensing are being used to combat the rising number of pharmacy closures and pharmacy deserts in underserved urban and rural areas.

Michael outlines a rapidly changing legal landscape—28 states now allow some form of telepharmacy, while 22 restrict or do not authorize it—resulting in complex supervision, licensing, and operational requirements for health systems and multistate operators. He reviews state-by-state approaches to pharmacist oversight, technician ratios, distance and site limits, interstate licensing models, and strict restrictions on controlled substance dispensing despite temporary federal flexibilities.

Finally, his article emphasizes several advantages of telepharmacy, including better adherence and outcomes for chronic diseases. Michael also provides policy suggestions to align state laws, update reimbursement methods, facilitate cross-state practice agreements, and promote technological innovations like secure kiosks and AI-powered adherence tools to improve health equity.

Read the full article (PDF).

U.S. Pharmacist: "The Evolving Telepharmacy Dispensing Landscape" (October 2025 Edition)

Hinshaw & Culbertson LLP is a U.S.-based law firm with offices nationwide. The firm's national reputation spans the insurance industry, the financial services sector, professional services, and other highly regulated industries. Hinshaw provides holistic legal solutions—from litigation and dispute resolution, and business advisory and transactional services, to regulatory compliance—for clients of all sizes. Visit www.hinshawlaw.com for more information and follow @Hinshaw on LinkedIn and X.